Şiran Keske - Infectious Diseases

Author Information

Şiran Keske is a renowned researcher affiliated with the American Hospital, Department of Infectious Diseases, located in Istanbul, Turkey. The affiliation suggests a strong background in clinical and research aspects of infectious diseases, contributing significantly to the understanding and management of these conditions.

Research Contributions

Şiran Keske has contributed extensively to the field of infectious diseases, with a notable focus on topics such as the prevention and management of nosocomial infections, antimicrobial resistance, and the clinical aspects of COVID-19. Some key studies include guidelines on testing for SARS-CoV-2 in asymptomatic individuals, investigations into carbapenem-resistant Klebsiella infections, and the effectiveness of bundle applications in preventing central line-associated bloodstream infections. Keske's work also delves into the implications of using specific treatments during the COVID-19 pandemic, such as hydroxychloroquine and favipiravir, highlighting the importance of careful medication use during concurrent influenza seasons.

Aliases

Şiran Keske is also known by several aliases, including S. Keske, Ş Keske, and Siran Keske. These variations may appear in different publications and databases.

Publication and Citation Metrics

Metric	Value
Citation Count	664
H-index	16
Paper Count	55

Publications:

ESCMID guidelines on testing for SARS-CoV-2 in asymptomatic individuals to prevent transmission in the health care setting

DOI: 10.1016/j.cmi.2022.01.007

Year: 2022

Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting.

DOI: 10.1007/s10096-022-04425-4

Year: 2022

The Effectiveness of Bundle Applications in the Prevention of Central Line-associated Bloodstream Infections: Nine Years of Observation

DOI: 10.36519/idcm.2022.114

Year: 2022

Elimination of healthcare associated Acinetobacter baumannii infection in a highly endemic region.

DOI: 10.1016/j.ijid.2021.10.011

Year: 2021

The role of Isolation of the Patients on Hospital Admission for Prevention of Nosocomial Infections

DOI: 10.36519/idcm.2021.35

Year: 2021

Changes in antimicrobial resistance and outcomes of health care-associated infections.

DOI: 10.1007/s10096-020-04140-y

Year: 2021

Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic?

DOI: 10.1016/j.ijid.2020.10.080

Year: 2021

The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis

DOI: 10.1016/j.cmi.2021.05.036

Year: 2021

Effectiveness of favipiravir in COVID-19: a live systematic review

DOI: 10.1007/s10096-021-04307-1

Year: 2021

Hydroxychloroquine in COVID-19: The predictors of QT Prolongation

DOI: 10.22541/au.159493001.17317894

Year: 2020

Why are Serological Tests Important?

How Do Antimicrobial Resistance and Infectious Diseases Relate?

Why is Surveillance Important?

Who is at Risk?

What Are the Long-Term Outcomes for Infected Children?

What Are the Common Concerns About Vaccines?

How Does Prevalence Differ from Incidence?

How is HSV Transmitted?

What is the correct way to wash your hands?

How Can Personal Hygiene Help in Infection Prevention?

Partnered Content Networks

Relevant Topics